Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients with valid NHS prescriptions for (a) molnupiravir and (b) similar antivirals were unable to obtain their medication within the recommended treatment window in the last 12 months.

The Department does not have information about the date of the onset of patient symptoms, which is the start of the five-day treatment window. The service level from the distributor in the last 12 months was 99.2% for molnupiravir and paxlovid, another COVID-19 antiviral, with the standard delivery being either the same day or the day after, in more remote locations.